{"id":"W2770837274","doi":"10.1016/j.jtho.2017.11.088","title":"P2.07-029 CheckMate 169: Safety/Efficacy of Nivolumab in Canadian Pretreated Advanced NSCLC (including Elderly and PS 2) Patients","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre; Royal Victoria Hospital; Lakeridge Health; Richmond Hospital; Dr. Georges-L.-Dumont University Hospital Centre; Interior Health; Thunder Bay Regional Health Sciences Centre; CancerCare Manitoba; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Hôpital Charles-Le Moyne; Cégep de Rimouski; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Nivolumab; Oncology; Internal medicine; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003690756,0.0002461608,0.0004871106,0.0002003624,0.0003493864,0.0006432713,0.0004343246,0.0003827715,0.00651427],"category_scores_gemma":[0.0008144245,0.0001217364,0.0006577595,0.0002746953,0.0002176724,0.0002581462,0.0001553457,0.0009039816,0.0008465911],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003387397,"about_ca_system_score_gemma":0.003578998,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.08299743,"about_ca_topic_score_gemma":0.2217784,"domain_scores_codex":[0.9998477,0.00002670243,0.000007788227,0.00002140924,0.00004796415,0.00004853763],"domain_scores_gemma":[0.9996762,0.00004289196,0.00006614926,0.00001463148,0.00007850694,0.0001216302],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.249004,0.003820894,0.1374316,0.001307862,0.002361291,0.0005443945,0.0001589312,0.002013439,0.02558426,0.001111842,0.0744527,0.5022088],"study_design_scores_gemma":[0.08805487,0.06121086,0.7202335,0.0006790968,0.004430837,0.001497906,0.000263508,0.005494877,0.01314818,0.0007451053,0.1040438,0.0001974862],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9631106,0.00962276,0.0001675548,0.002441897,0.000345762,0.0003316985,0.007144814,0.0001818347,0.01665297],"genre_scores_gemma":[0.98769,0.002066408,0.0003527885,0.0009944728,0.0001122269,0.00005382497,0.004194648,0.0000198645,0.004515832],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9170026,"threshold_uncertainty_score":0.1650287,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02399201325622598,"score_gpt":0.3946249118355802,"score_spread":0.3706328985793543,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}